Hai cercato la traduzione di fluvoxamine da Maltese a Inglese

fluvoxamine u inibituri ta’ cyp1a2
fluvoxamine and inhibitors of cyp1a2

fluvoxamine kienet 54% fin- nisa li ma
the mean increase in olanzapine cmax following fluvoxamine was 54% in female non- smokers and 77% male smokers.

fluvoxamine li jintuża biex jikkura d- dipressjoni
fluvoxamine used to treat depression

użu konkomitanti ta’ fluvoxamine (ara sezzjoni 4.5).
concomitant use of fluvoxamine (see section 4.5).

91 jużaw fluvoxamine jew xi inibituri oħra ta 'cyp1a2, bħal ciprofloxacin.
a lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other cyp1a2 inhibitors, such as ciprofloxacin.

25 qed jużaw fluvoxamine jew xi inibituri oħra ta ’ cyp1a2, bħal ciprofloxacin.
a lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other cyp1a2 inhibitors, such as ciprofloxacin.

- jekk tieħu xi mediċina li fiha fluoxetine, fluvoxamine, dextromethorphan jew simpatomimetiċi,
- if you take medicines containing fluoxetine, fluvoxamine, dextromethorphan or

inibturi tas-cyp2c19 b’saħħithom (eż. omeprazole, fluvoxamine u moclobemide)
strong cyp2c19 inhibitors (e.g. omeprazole, fluvoxamine and moclobemide)

fluvoxamine (100 mg darba kuljum), inibitur qawwi ta ’ cyp1a2, naqqas it -
fluvoxamine (100 mg once daily), a potent inhibitor of cyp1a2, decreased the apparent plasma clearance of duloxetine by about 77% and increased auc0-t 6-fold.

- jekk qiegħed/ qiegħda tieħu fluvoxamine li normalment jintuża għall- kura tad- dipressjoni,
- if you are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or

fluvoxamine, inibitur speċifiku ta' cyp1a2, deher li jinibixxi sinifikatament il- metaboliżmu ta 'olanzapine.
fluvoxamine, a specific cyp1a2 inhibitor, has been shown to significantly inhibit the metabolism of olanzapine.

qed tieħ fluvoxamine (anti- dipressant), jew ciprofloxacin (antibijotiku), għ jista 'jkun hemm
you might feel drowsy if zalasta is taken in combination with these medicines,  if you are taking fluvoxamine (an antidepressant), or ciprofloxacin (an antibiotic), as it may be necessary to change your zalasta dose.

biex tibda trattament b’ fluoxetine jew fluvoxamine, trid tistenna mill-inqas 14 il-ġurnata minn meta twaqqaf azilect.
if you are starting treatment with fluoxetine or fluvoxamine, you should wait at least 14 days after stopping azilect treatment.

użu flimkien ta’ impedituri qawwija cyp1a2 (bħal fluvoxamine, ciprofloxacin) (ara sezzjoni 4.5).
concomitant use of potent cyp1a2 inhibitors (e.g. fluvoxamine, ciprofloxacin) (see section 4.5).

l-użu ta’ rasagiline flimkien ma’ fluoxetine jew fluvoxamine għandu jiġi evitat (ara sezzjoni 4.5).
the concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.5).

inibizzjoni ta 'cyp1a2 fluvoxamine, inibitur speċifiku ta' cyp1a2, deher li jinibixxi sinifikatament il- metaboliżmu ta' olanzapine.
inhibition of cyp1a2 fluvoxamine, a specific cyp1a2 inhibitor, has been shown to significantly inhibit the metabolism of olanzapine.

mediċini għall-kura ta’ disturbi ta’ ansjetà u d-dipressjoni (eż. alprazolam, fluoxetine, fluvoxamine)
medicines to treat anxiety disorders and depression (e.g. alprazolam, fluoxetine, fluvoxamine)

għaldaqstant, ariclaim m’għandux jingħata flimkien ma’ inibituri qawwija ta’ cyp1a2 bħal fluvoxamine (ara sezzjoni 4.3).
therefore ariclaim should not be administered in combination with potent inhibitors of cyp1a2 like fluvoxamine (see section 4.3).

fluvoxamine għandu jitwaqqaf qabel tibda t-terapija b’esbriet u evitat waqt it-terapija b’esbriet minħabba t-tneħħija mnaqqsa ta’ pirfenidone.
fluvoxamine should be discontinued prior to the initiation of esbriet therapy and avoided during esbriet therapy due to the reduced clearance of pirfenidone.